Levitra 20mg film-coated tablets
Last Updated on eMC 23-Dec-2015 View document | Bayer plc Contact details
Versions
- 23-Dec-2015 to Current
- 03-Jun-2014 to 23-Dec-2015
- 07-Apr-2014 to 03-Jun-2014
- 25-Apr-2013 to 07-Apr-2014
- 22-May-2012 to 25-Apr-2013
- 18-May-2012 to 22-May-2012
- 08-Mar-2012 to 18-May-2012
- 23-Aug-2011 to 08-Mar-2012
- 10-Jun-2011 to 23-Aug-2011
- 28-Jul-2009 to 10-Jun-2011
- 11-Aug-2008 to 28-Jul-2009
- 15-Jul-2008 to 11-Aug-2008
- 24-Jan-2008 to 15-Jul-2008
- 05-Jul-2006 to 24-Jan-2008
- 25-Nov-2005 to 05-Jul-2006
- 10-Nov-2005 to 25-Nov-2005
- 03-Jun-2005 to 10-Nov-2005
- 28-Jun-2004 to 03-Jun-2005
- 12-Sep-2003 to 28-Jun-2004
- 11-Mar-2003 to 12-Sep-2003
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 23-Dec-2015 and displayed until Current
Reasons for adding or updating:
- Change to section 2 - what you need to know - contraindications
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 6 - date of revision
Updated on 03-Jun-2014 and displayed until 23-Dec-2015
Reasons for adding or updating:
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - how to report a side effect
- Change to section 6 - date of revision
Updated on 07-Apr-2014 and displayed until 03-Jun-2014
Reasons for adding or updating:
- Change to other sources of information section
Updated on 25-Apr-2013 and displayed until 07-Apr-2014
Reasons for adding or updating:
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
Updated on 22-May-2012 and displayed until 25-Apr-2013
Reasons for adding or updating:
- Improved Electronic Presentation
Updated on 18-May-2012 and displayed until 22-May-2012
Reasons for adding or updating:
- Improved Electronic Presentation
- PIL Submitted in error
Updated on 08-Mar-2012 and displayed until 18-May-2012
Reasons for adding or updating:
- Change to date of revision
Updated on 23-Aug-2011 and displayed until 08-Mar-2012
Reasons for adding or updating:
- Change to date of revision
- Change to Marketing Authorisation Holder
Updated on 10-Jun-2011 and displayed until 23-Aug-2011
Reasons for adding or updating:
- Change to Further Information section
- Change to date of revision
- Change to warnings or special precautions for use
- Change of contra-indications
Updated on 28-Jul-2009 and displayed until 10-Jun-2011
Reasons for adding or updating:
- Change to date of revision
- Change to Marketing Authorisation Holder
- Change to name of manufacturer
Updated on 11-Aug-2008 and displayed until 28-Jul-2009
Reasons for adding or updating:
- Change to side-effects
- Change to warnings or special precautions for use
Updated on 15-Jul-2008 and displayed until 11-Aug-2008
Reasons for adding or updating:
- Change to side-effects
Updated on 24-Jan-2008 and displayed until 15-Jul-2008
Reasons for adding or updating:
- Change to side-effects
- Change to side-effects
- PIL Retired pending re-submission
Updated on 05-Jul-2006 and displayed until 24-Jan-2008
Reasons for adding or updating:
- Change to warnings or special precautions for use
- Change of contra-indications
- Change to side-effects
- Change to date of revision
Updated on 25-Nov-2005 and displayed until 05-Jul-2006
Reasons for adding or updating:
- Change to warnings or special precautions for use
- Change to side-effects
- Change to date of revision
Updated on 10-Nov-2005 and displayed until 25-Nov-2005
Reasons for adding or updating:
- Change of manufacturer
- Change to date of revision
Updated on 03-Jun-2005 and displayed until 10-Nov-2005
Reasons for adding or updating:
- Change to side-effects
- Change to date of revision
Updated on 28-Jun-2004 and displayed until 03-Jun-2005
Reasons for adding or updating:
- Change to side-effects
Updated on 12-Sep-2003 and displayed until 28-Jun-2004
Reasons for adding or updating:
- Update to PIL
Updated on 11-Mar-2003 and displayed until 12-Sep-2003
Reasons for adding or updating:
- New PIL for new product
Bayer plc
Bayer House, Strawberry Hill, Newbury, Berkshire, RG14 1JA
+44 (0)1635 563 393
+44 (0)1635 563 000
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue